This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (14)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

RICHARD H. JESSE, MD; RENE VILLARREAL, MD; VICTOR LETAYF, MD; CARLOS RUFINO, MD; ROBERT C. HICKEY, MD

AMA Arch Surg. 1964;88(4):618-627.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since Klopp, in 1950,⁷ first injected the cancer chemotherapeutic drug, mechlorethamine hydrochloride (nitrogen mustard), into the arterial supply of a tumor, surgeons have been interested in this method of testing new drugs. Although the search for a compound which is lethal to cancer cells without disturbing the patient or his normal cells has been continuous, this utopain objective is still unachieved. The drugs made available, however, have been tested clinically by regional infusion and perfusion, as well as systemically, in an attempt to discover the most effective, yet safest dosage and method of administration for a specific type of tumor.

Regional perfusion with the use of the pump oxygenator closed circuit technique was instituted in the M. D. Anderson Hospital¹⁰ in 1957, and as of October, 1963, a total of 391 perfusions had been performed on 296 patients.¹¹ Early in our experience, it was found that certain . . . [Full Text PDF of this Article]

Author Affiliations
HOUSTON

Fellows in Surgery, supported by American Cancer Society, Texas Division (Dr. Villarreal, Dr. Letayf, and Dr. Rufino).; The University of Texas M. D. Anderson Hospital and Tumor Institute.

Footnotes
Read before the 71st Annual Session of the Western Surgical Association, Galveston, Tex, Nov 21-23, 1963.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?